Curi Bio
Cart 0
Request a Quote Contact
Platforms Overview Biosystem Platforms Mantarray™ – 3D Tissue Contractility Analysis Mantarray Mini Plates – Fewer Cells. More Data. Nautilus Plus™ – 3D Tissue Contractility and Fluorescence at Scale Nautilai™ – Voltage & Calcium Imaging Stingray™ – Stimulation and Maturation of 3D Engineered Tissues NanoSurface™ Plates – HCI Plates for Structural Maturation Data Analytics Platforms Pulse™ – High-Throughput Video Contractility Analysis Software
Models Overview Applications Neuromuscular Junction Model DM1 Model Skeletal Muscle Models Cardiac Models Disease Models Cells & Media Metabolic Media 3D Skeletal Muscle Tissue Media Skeletal Muscle Myoblasts 3D Cardiac Media MYBPC3 HCM Cardiomyocytes Celogics Celo.Cardiomyocytes
Curi Engine Services Curi Engine™ Services
Publications Publications Application Notes Product Literature Webinars Posters Videos Knowledge Base
Company Company Events – Workshop World Tour News Blog Distributors Careers
Cart 0
PLATFORMS Platforms Overview Biosystem Platforms Mantarray™ – 3D Tissue Contractility Analysis Mantarray Mini Plates – Fewer Cells. More Data. Nautilus Plus™ – 3D Tissue Contractility and Fluorescence at Scale Nautilai™ – Voltage & Calcium Imaging Stingray™ – Stimulation and Maturation of 3D Engineered Tissues NanoSurface™ Plates – HCI Plates for Structural Maturation Data Analytics Platforms Pulse™ – High-Throughput Video Contractility Analysis Software MODELS Models Overview Applications Neuromuscular Junction Model DM1 Model Skeletal Muscle Models Cardiac Models Disease Models Cells & Media Metabolic Media 3D Skeletal Muscle Tissue Media Skeletal Muscle Myoblasts 3D Cardiac Media MYBPC3 HCM Cardiomyocytes Celogics Celo.Cardiomyocytes SERVICES Curi Engine Services Curi Engine™ Services RESOURCES Publications Publications Application Notes Product Literature Webinars Posters Videos Knowledge Base ABOUT Company Company Events – Workshop World Tour News Blog Distributors Careers
Curi Bio
Request a QuoteContact

News

Stay Up-to-Date on All Curi Bio News

Subscribe to Curi Bio’s Newsletter

 
cardiomyocytes-two.jpg
Curi Bio Launches the Curiverse™ at MPS 2026: The Industry's First Closed-Loop Ecosystem for Industrial-Scale, Human-Relevant Drug Discovery
Curi Bio Launches the Curiverse™ at MPS 2026: The Industry's First Closed-Loop Ecosystem for Industrial-Scale, Human-Relevant Drug Discovery
Jacqueline De RoseJune 1, 2026
Curi Bio and Battelle Announce Strategic Partnership to Accelerate the Adoption of NAMs in Neuromuscular Pharmacology
Curi Bio and Battelle Announce Strategic Partnership to Accelerate the Adoption of NAMs in Neuromuscular Pharmacology
Arianna KieserMarch 20, 2026
Curi Bio Launches Asia-Pacific Hub, Delivering Greater Support to its Growing APAC Business
Curi Bio Launches Asia-Pacific Hub, Delivering Greater Support to its Growing APAC Business
Arianna KieserJanuary 12, 2026
Curi Bio Secures $10M Series B to Scale Human-Relevant Preclinical Platforms and Advanced Data Analysis for Drug Discovery
Curi Bio Secures $10M Series B to Scale Human-Relevant Preclinical Platforms and Advanced Data Analysis for Drug Discovery
Arianna KieserDecember 2, 2025
Curi Bio and Cook MyoSite Announce Strategic Partnership
Curi Bio and Cook MyoSite Announce Strategic Partnership
Press ReleasesArianna KieserApril 30, 2025
Curi Bio Celebrates Grand Opening of New Global Headquarters in Seattle
Curi Bio Celebrates Grand Opening of New Global Headquarters in Seattle
Press ReleasesArianna KieserApril 8, 2025
Curi Bio Unlocks Advanced Cardiac Insights with Novoheart Integration
Curi Bio Unlocks Advanced Cardiac Insights with Novoheart Integration
Arianna KieserDecember 19, 2024
Curi Bio Recognized as a 2024 Deloitte Technology Fast 500 Winner
Curi Bio Recognized as a 2024 Deloitte Technology Fast 500 Winner
Arianna KieserNovember 22, 2024
Muscle disease researchers receive cutting-edge equipment to test new treatments
Muscle disease researchers receive cutting-edge equipment to test new treatments
Arianna KieserSeptember 18, 2024
Mantarray™ Mini Plates: Fewer Cells. More Data.
Mantarray™ Mini Plates: Fewer Cells. More Data.
Arianna KieserSeptember 9, 2024
Curi Bio’s Growth Propels Move to Prime Seattle Location to Advance Cutting-Edge Drug Discovery Research
Curi Bio’s Growth Propels Move to Prime Seattle Location to Advance Cutting-Edge Drug Discovery Research
Arianna KieserAugust 22, 2024
Curi Bio, Genetox, and DreamCIS Sign MOU for Strategic Collaboration on 3D Neuromuscular Junction Model for Botox Potency Assay
Curi Bio, Genetox, and DreamCIS Sign MOU for Strategic Collaboration on 3D Neuromuscular Junction Model for Botox Potency Assay
Press ReleasesArianna KieserFebruary 22, 2024
Nautilai™: The Evolution of Nautilus
Nautilai™: The Evolution of Nautilus
Arianna KieserDecember 27, 2023
Entrada Therapeutics Highlights Mantarray Data at Frontiers in Myogenesis Conference 2023
Entrada Therapeutics Highlights Mantarray Data at Frontiers in Myogenesis Conference 2023
Arianna KieserNovember 7, 2023
Curi Bio Launches Nautilus™ and Stingray™ Platforms for Advancing Translational Research
Curi Bio Launches Nautilus™ and Stingray™ Platforms for Advancing Translational Research
Press ReleasesArianna KieserSeptember 18, 2023
Curi Bio Awarded Over $4.4M in NIH Grants to Advance Translational Science
Curi Bio Awarded Over $4.4M in NIH Grants to Advance Translational Science
Press ReleasesArianna KieserAugust 23, 2023
Curi Bio Launches MantaReady™ iPSC-Derived Skeletal Muscle Myoblasts
Curi Bio Launches MantaReady™ iPSC-Derived Skeletal Muscle Myoblasts
Press ReleasesArianna KieserJune 6, 2023
[JoVE Video] Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
[JoVE Video] Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
Arianna KieserMay 4, 2023
Curi Bio Launches MantaReady™ 3D Skeletal Muscle Tissue Media
Curi Bio Launches MantaReady™ 3D Skeletal Muscle Tissue Media
Arianna KieserMarch 14, 2023
Curi Bio Names Nicholas Geisse, Ph.D., as New Chief Executive Officer
Curi Bio Names Nicholas Geisse, Ph.D., as New Chief Executive Officer

Curi Bio Names Nicholas A. Geisse, Ph.D., as New Chief Executive Officer

Read More
Press ReleasesArianna KieserFebruary 14, 2023
Older

Speak with a Team Member

Curi Bio is a science-first organization that offers best-in-class products and technical support. Our team of experts is standing by to help you succeed.

Contact Us

Company Info

201 Elliott Avenue West, Seattle, WA 98119, USA
Phone: 1 (800) 913-4403
Email: contact@curibio.com

Subscribe to Newsletter

Mantarray™
3D Engineered Tissue Contractility Analysis

Cytostretcher™
Cell Stretching Instruments

NanoSurface™ Plates
Structural Maturation of Cardiac & Skeletal Muscle Cultures

We can help.
Utilize the Curi Engine™ for:

  • Compound Profiling/Screening
  • Assay/Model Development
  • Discovery

Cardiac Tissue Models

  • 2D Heart Models
  • 3D Engineered Heart Tissues (EHTs)

Skeletal Muscle Tissue Models

  • 2D Skeletal Muscle Models
  • 3D Engineered Muscle Tissues (EMTs)

Product Literature

Application Notes

Peer-reviewed Publications

Knowledge Base

Company

News

Events

Distributors

Careers

Shipping & ReturnsTerms & Privacy
 
Fast-500_482x50.png
Awards-04.png
Awards-05.png
Awards-06.png
Awards-08.png